Ardelyx (ARDX) Return on Sales Growth (3y) (2018 - 2026)

Ardelyx (ARDX) Return on Sales Growth (3y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Ardelyx 1.26 Bn 1.02 Bn 89.66 Mn 2.00

Historic Data

Download Data
DateValue
Mar 31, 2026 2.00
Dec 31, 2025 0.00
Sep 30, 2025 4.00
Jun 30, 2025 10.00
Mar 31, 2025 59.00
Dec 31, 2024 35.00
Sep 30, 2024 37.00
Jun 30, 2024 34.00
Mar 31, 2024 4.00
Dec 31, 2023 15.00
Sep 30, 2023 7.00
Jun 30, 2023 13.00
Mar 31, 2023 16.00
Dec 31, 2022 9.00
Sep 30, 2022 3.00
Jun 30, 2022 1,404.00
Mar 31, 2022 290.00
Dec 31, 2021 293.00
Sep 30, 2021 103.00
Jun 30, 2021 709.00